SCHEMBL1430757

SCHEMBL1430757

Cc1onc(C(N)=O)c1-c1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.49
PIK3CB P42338 4/20 0.49
PIM1 P11309 2/20 0.49
GSK3B P49841 2/20 0.49
PIK3CA P42336 2/20 0.48
PIK3CG P48736 2/20 0.48
BTK Q06187 4/20 0.39
TEC P42680 3/20 0.39
BMX P51813 3/20 0.39
LCK P06239 3/20 0.38
BLK P51451 2/20 0.38
ITK Q08881 2/20 0.38
LYN P07948 1/20 0.38
HCK P08631 1/20 0.38
FGR P09769 1/20 0.38
SRC P12931 1/20 0.38
FRK P42685 1/20 0.38
LIMK1 P53667 1/20 0.38
ACVR1 Q04771 1/20 0.38
TNK2 Q07912 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL459116 0.80 PIK3CD (0.59) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL1119167 0.78 PIK3CD (0.56) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL1431437 0.77 PIK3CD (0.55) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL461789 0.76 PIK3CD (0.48) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL1431305 0.74 PIK3CD (0.55) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL2216485 0.74 PIK3CD (0.58) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL470091 0.73 PIK3CD (0.58) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL463054 0.73 PIK3CD (0.51) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL1430759 0.72 PIK3CD (0.72) PIK3CDPIK3CBPIM1GSK3BPIK3CA
SCHEMBL1431039 0.72 PIK3CD (0.49) PIK3CDPIK3CBPIM1GSK3BPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300437-A1 BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES Glaxo Group Limited (GB) 2011-03-30 EP disclosed